Upgrade to SI Premium - Free Trial

Phio Pharmaceuticals Corp. (PHIO)

0.91 +0.02 (2.25%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series October 19, 2026 9:55 AM - StreetInsider Form 8-K Phio Pharmaceuticals For: Oct 13 October 13, 2026 8:42 AM - SEC Filing Phio Pharma completes first commercial-scale cGMP batch of PH-762 October 13, 2026 7:05 AM - StreetInsider Phio Pharmaceuticals Announces Successful Completion of First Commercial-Scale cGMP Batch of PH-762 Drug Substance October 13, 2026 7:03 AM - StreetInsider OTC Markets Group Announces Third Annual Global Markets Forum Presentations Now Available On Demand October 12, 2026 8:35 AM - StreetInsider Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026 October 6, 2026 7:01 AM - StreetInsider OTC Markets Group Announces Agenda for Third Annual Global Markets Forum, October 7th & 8th October 5, 2026 8:35 AM - Globe NewsWire OTC Markets Group Announces Agenda for Third Annual Global Markets Forum, October 7th & 8th October 5, 2026 8:35 AM - StreetInsider Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference October 5, 2026 7:02 AM - StreetInsider Form 4 Phio Pharmaceuticals For: Sep 28 Filed by: Plott Ronald Todd September 30, 2026 4:01 PM - SEC Filing Form 4 Phio Pharmaceuticals For: Sep 28 Filed by: Plott Ronald Todd September 29, 2026 4:01 PM - SEC Filing Form 4 Phio Pharmaceuticals For: Sep 28 Filed by: Bitterman Robert J September 29, 2026 4:01 PM - SEC Filing Form 4 Phio Pharmaceuticals For: Sep 28 Filed by: Carson Lisa Cabott September 29, 2026 4:01 PM - SEC Filing Form S-8 Phio Pharmaceuticals September 28, 2026 4:33 PM - SEC Filing Form 8-K Phio Pharmaceuticals For: Sep 28 September 28, 2026 4:02 PM - SEC Filing Form 4 Phio Pharmaceuticals For: Sep 24 Filed by: BRADFORD PATRICIA A September 25, 2026 4:01 PM - SEC Filing Form 4 Phio Pharmaceuticals For: Sep 22 Filed by: Bitterman Robert J September 23, 2026 4:01 PM - SEC Filing Phio Pharmaceuticals to Present Clinical Development Update and Upcoming Catalysts at Life Sciences Future 2026 Conference September 23, 2026 7:01 AM - StreetInsider Form 4 Phio Pharmaceuticals For: Sep 15 Filed by: BRADFORD PATRICIA A September 16, 2026 4:01 PM - SEC Filing Form 4 Phio Pharmaceuticals For: Sep 11 Filed by: Bitterman Robert J September 15, 2026 4:00 PM - SEC Filing Form 4 Phio Pharmaceuticals For: Sep 11 Filed by: Carson Lisa Cabott September 15, 2026 4:00 PM - SEC Filing Form 8-K Phio Pharmaceuticals For: Sep 14 September 14, 2026 9:00 AM - SEC Filing Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma September 14, 2026 7:03 AM - StreetInsider Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma September 14, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference September 11, 2026 9:02 AM - StreetInsider Form 4 Phio Pharmaceuticals For: Aug 19 Filed by: Plott Ronald Todd August 20, 2026 8:30 AM - SEC Filing Form 4 Phio Pharmaceuticals For: Aug 18 Filed by: Bitterman Robert J August 19, 2026 4:01 PM - SEC Filing Form ARS Phio Pharmaceuticals For: Dec 31 August 14, 2026 4:19 PM - SEC Filing Form DEFA14A Phio Pharmaceuticals August 14, 2026 4:18 PM - SEC Filing Form DEF 14A Phio Pharmaceuticals For: Sep 28 August 14, 2026 4:08 PM - SEC Filing Phio Pharmaceuticals receives U.S. patent allowance for PH-894 August 11, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894 August 11, 2026 7:02 AM - StreetInsider Phio Pharmaceuticals Corp. (PHIO) Misses Q2 EPS by 6c August 6, 2026 6:04 PM - StreetInsider Form 8-K Phio Pharmaceuticals For: Aug 06 August 6, 2026 4:22 PM - SEC Filing Form 10-Q Phio Pharmaceuticals For: Jun 30 August 6, 2026 4:19 PM - SEC Filing Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update August 6, 2026 4:07 PM - StreetInsider Form 3 Phio Pharmaceuticals For: Jul 20 Filed by: Plott Ronald Todd July 30, 2026 4:01 PM - SEC Filing Full Article List